Adrenomedullin (ADM) inhibits endothelial insulin signaling, contributing to obesity-associated insulin resistance, according ...
Researchers investigate the underlying mechanisms of endothelial insulin resistance involved in obesity-associated diabetes.
Adrenomedullin disrupts insulin signaling in blood vessels, leading to systemic insulin resistance in obesity-associated type 2 diabetes.
If insulin can’t get out of blood vessels, it can’t act in its target tissues. “Endothelial cells are full of insulin ...
Innovative designs of GPCRs with enhanced signaling and stability offer new insights for drug discovery and synthetic biology ...
A new study published in Biochemistry sheds light on how bacteria regulate their genes, challenging long-held assumptions ...
Basic science researchers at the Johns Hopkins University School of Medicine are advancing heart health research by finding ...
The hormone adrenomedullin disrupts insulin signaling in blood vessel cells, contributing to systemic insulin resistance in obesity-associated type 2 diabetes, according to a new study.
Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer Twenty-eight patients underwent apheresis and received CAR T cells. Sixteen and 12 patients ...